The role of O-linked N-Acetylglucosamine Homeostasis in Pancreatic Beta-cell Development and Function
O-连接的 N-乙酰氨基葡萄糖稳态在胰腺 β 细胞发育和功能中的作用
基本信息
- 批准号:10158468
- 负责人:
- 金额:$ 38.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Type 2 diabetes (T2D) is the most common chronic disease affecting human health. Recent longitudinal and genome-wide association studies provide strong evidence that the ability of pancreatic β-cells to fulfill insulin demand through development, growth, survival, and function is a key determinant of whether an individual will develop T2D ! under various nutrient conditions. However, there are no effective clinical treatments that target β-cell growth and maintenance of their differentiated identity as insulin producing-cells. We propose that OGT (O-GlcNAc Transferase), a nutrient-sensor expressed at a very high level in β-cells, has key developmental regulatory properties and the ability to integrate signaling networks to regulate β-cell plasticity in response to insulin demand and nutrient stress. OGT is the sole enzyme adding a single O-GlcNAc post-translational modification (O-GlcNAcylation) onto proteins to orchestrate and fine-tune glucose metabolism, and β-cell growth and maintenance of identity under stress responses to nutrient changes and hormonal cues. We hypothesize that OGT tightly controls the O-GlcNAcylation state of downstream targets, including Pdx1, to promote β-cell development and function. Thus, our long-term goal is to define the mechanisms of how OGT integrates signaling networks impinging on β-cell plasticity (development and identity) to promote functional β-cells. We will test our hypothesis with the following Aims: 1. To establish the molecular mechanisms of how OGT regulates β-cell development and mass. 2. To delineate the mechanisms of how OGT regulates β-cell mass and identity under metabolic stress. The impact of this grant will show the central role of OGT in β-cell development and mass maintenance, and illustrate the translational relevance of OGT during time windows critical to metabolic health . Finally, these results will advance the field of β-cell biology and will open new horizons for therapies for patients with diabetes.
2型糖尿病(T2D)是影响人类健康的最常见慢性疾病。最近的纵向和全基因组关联研究提供了有力的证据,表明胰腺β细胞通过发育,增长,生存和功能来满足胰岛素需求的能力是个人是否会发展T2D的关键确定基因!在各种营养条件下。但是,尚无有效的临床治疗方法,可以靶向β细胞生长和维持其分化为胰岛素生产细胞的认同。我们提出,OGT(O-GLCNAC转移酶)是一种在β细胞中非常高的营养传感器,具有关键的发育调节性能,并且具有整合信号网络以响应胰岛素需求和养分应激而整合信号网络以调节β细胞可塑性的能力。 OGT是唯一的酶,在蛋白质上添加了单个O-GLCNAC翻译后修饰(O-Glcnacylation),以协调和微调葡萄糖代谢,并在养分变化和和谐提示的压力反应下进行β细胞的生长以及对身份的维持。我们假设OGT紧紧控制了包括PDX1在内的下游靶标的O-Glcnacylation状态,以促进β细胞的发育和功能。这就是我们的长期目标是定义OGT如何整合撞击β细胞可塑性(发展和身份)以促进功能性β细胞的机制。我们将以以下目的检验我们的假设:1。建立OGT如何调节β细胞发育和质量的分子机制。 2。描述OGT如何调节代谢应激下β细胞质量和身份的机制。这笔赠款的影响将显示OGT在β细胞开发和质量维持中的核心作用,并说明了OGT在时间窗口中对代谢健康至关重要的转化相关性。最后,这些结果将推进β细胞生物学领域,并将为糖尿病患者的疗法开辟新的视野。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Emilyn Alejandro的其他基金
Nutrient-sensor O-GlcNAc Transferase Regulation of Autophagy in Homeostatis of Pancreatic Beta-cell Mass and Function
营养传感器 O-GlcNAc 转移酶对胰腺 β 细胞质量和功能稳态中自噬的调节
- 批准号:1090787410907874
- 财政年份:2023
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Placental Insulin Signaling and mTOR Nutrient-Sensing Programming of Offspring Metabolic Health
胎盘胰岛素信号传导和 mTOR 营养感应编程对后代代谢健康的影响
- 批准号:1067975610679756
- 财政年份:2023
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Placental Insulin Signaling and mTOR Nutrient-Sensing Programming of Offspring Metabolic Health
胎盘胰岛素信号传导和 mTOR 营养感应编程对后代代谢健康的影响
- 批准号:1062593810625938
- 财政年份:2022
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Innate Immune Complement System and Developmental Programming of Functional β Cell Mass
先天免疫补体系统和功能性β细胞群的发育编程
- 批准号:1019457410194574
- 财政年份:2020
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
The role of O-linked N-Acetylglucosamine Homeostasis in Pancreatic Beta-cell Development and Function
O-连接的 N-乙酰氨基葡萄糖稳态在胰腺 β 细胞发育和功能中的作用
- 批准号:1040625510406255
- 财政年份:2018
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
The role of O-linked N-Acetylglucosamine Homeostasis in Pancreatic Beta-cell Development and Function
O-连接的 N-乙酰氨基葡萄糖稳态在胰腺 β 细胞发育和功能中的作用
- 批准号:99229009922900
- 财政年份:2018
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
O-linked-N-acetylglucosamine Post-translational Modification in Pancreatic Beta-cells Regulating ER Stress and Mitochondrial Function
胰腺β细胞中的O-连接-N-乙酰氨基葡萄糖翻译后修饰调节内质网应激和线粒体功能
- 批准号:93877659387765
- 财政年份:2017
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Mechanisms of Developmental Programing of beta-cell Susceptibility to Glucolipotoxicity
β细胞对糖脂毒性敏感性的发育规划机制
- 批准号:92857799285779
- 财政年份:2014
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Mechanisms of Developmental Programing of beta-cell Susceptibility to Glucolipotoxicity
β细胞对糖脂毒性敏感性的发育规划机制
- 批准号:88043768804376
- 财政年份:2014
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Mechanisms of Developmental Programing of beta-cell Susceptibility to Glucolipotoxicity
β细胞对糖脂毒性敏感性的发育规划机制
- 批准号:91762149176214
- 财政年份:2014
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Resident Memory T cells in Chronic Kidney Disease
慢性肾脏病中的常驻记忆 T 细胞
- 批准号:1067662810676628
- 财政年份:2023
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Role of meningeal lymphatic vasculature in neuroimmune communication development
脑膜淋巴管系统在神经免疫通讯发育中的作用
- 批准号:1056668210566682
- 财政年份:2023
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma
TAZ 和 YAP 在 3D 基因组组织 DNA 损伤修复中的新作用以及胶质母细胞瘤的治疗耐药性
- 批准号:1064983010649830
- 财政年份:2023
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Ultrasound-guided Ultra-steerable Histotripsy Array System for Non-invasive treatment of Soft Tissue Sarcoma
超声引导超可控组织解剖阵列系统用于软组织肉瘤的无创治疗
- 批准号:1064999410649994
- 财政年份:2023
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Allogeneic BAFF Ligand Based CAR T-Cells as a Novel Therapy for Systemic Lupus Erythematous
基于同种异体 BAFF 配体的 CAR T 细胞作为系统性红斑狼疮的新疗法
- 批准号:1076100310761003
- 财政年份:2023
- 资助金额:$ 38.5万$ 38.5万
- 项目类别: